Published in Arch Neurol on December 01, 2012
Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline. N Engl J Med (2015) 1.97
Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease. Neurol Neuroimmunol Neuroinflamm (2015) 0.85
Ascertainment bias causes false signal of anticipation in genetic prion disease. Am J Hum Genet (2014) 0.79
Prion Diseases. Continuum (Minneap Minn) (2015) 0.78
Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract (2015) 0.76
Development of a dot blot assay with antibodies to recombinant "core" 14-3-3 protein: Evaluation of its usefulness in diagnosis of Creutzfeldt-Jakob disease. Ann Indian Acad Neurol (2016) 0.75
Sporadic Creutzfeldt-Jakob disease (sCJD) with asymmetric findings. BMJ Case Rep (2014) 0.75
Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic Features. Front Aging Neurosci (2016) 0.75
Case Studies Illustrating Focal Alzheimer's, Fluent Aphasia, Late-Onset Memory Loss, and Rapid Dementia. Neurol Clin (2016) 0.75
Sporadic Creutzfeldt-Jakob disease with unusual initial presentation as posterior reversible encephalopathy syndrome: a case report. BMC Neurol (2016) 0.75
Activation of pro-survival CaMK4β/CREB and pro-death MST1 signaling at early and late times during a mouse model of prion disease. Virol J (2014) 0.75
Three sporadic cases of Creutzfeldt-Jakob disease in China and their clinical analysis. Exp Ther Med (2017) 0.75
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol (1979) 5.53
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2003) 3.20
Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology (2004) 2.76
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry (1984) 2.68
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol (2011) 1.86
Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 1.82
How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain (1999) 1.71
Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology (2006) 1.61
Rapidly progressive dementia. Neurol Clin (2007) 1.58
First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia (2010) 1.45
Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull (2003) 1.41
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.39
Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol (2004) 1.14
Rapidly progressive dementia: causes found in a Greek tertiary referral center in Athens. Alzheimer Dis Assoc Disord (2009) 1.04
Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol (2006) 1.02
A 54-year-old man with slowness of movement and confusion. Neurology (2007) 1.01
Emerging pharmacotherapies for Creutzfeldt-Jakob disease. Arch Neurol (2006) 1.01
Clinical trials for prion disease: difficult challenges, but hope for the future. Lancet Neurol (2009) 0.90
Creutzfeldt-Jakob disease in Japan. Neurology (1983) 0.89
The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol (1999) 0.88
Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease. Can J Neurol Sci (2012) 0.79
[Creutzfeldt-Jakob disease, an ataxic type (Brownell-Oppenheimer)]. Rinsho Shinkeigaku (1976) 0.77
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (2005) 8.55
Synthetic mammalian prions. Science (2004) 7.35
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia (2010) 5.64
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain (2010) 3.84
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry (2010) 3.66
Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol (2003) 3.66
A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron (2002) 3.36
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2003) 3.20
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11
Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron (2012) 3.07
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol (2008) 2.96
Neuroanatomical correlates of behavioural disorders in dementia. Brain (2005) 2.92
Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J (2007) 2.85
Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol (2008) 2.80
Unravelling Boléro: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain (2007) 2.75
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69
Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol (2009) 2.68
Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A (2009) 2.41
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol (2008) 2.41
Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol (2006) 2.38
Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol (2005) 2.36
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Structural anatomy of empathy in neurodegenerative disease. Brain (2006) 2.28
Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol (2006) 2.27
Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol (2013) 2.26
Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness. Proc Natl Acad Sci U S A (2002) 2.24
Connected speech production in three variants of primary progressive aphasia. Brain (2010) 2.19
Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A (2013) 2.19
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Protease-sensitive synthetic prions. PLoS Pathog (2010) 2.14
Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13
Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. Arch Neurol (2003) 2.12
Asymptomatic deer excrete infectious prions in faeces. Nature (2009) 2.10
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol (2004) 2.07
Transmission of elk and deer prions to transgenic mice. J Virol (2006) 2.03
TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol (2007) 2.02
Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol Aging (2011) 2.01
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01
Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline. N Engl J Med (2015) 1.97
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain (2013) 1.91
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol (2014) 1.90
Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology (2007) 1.88
Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. J Biol Chem (2011) 1.88
Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody. Epilepsia (2009) 1.88
Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex (2011) 1.87
Clinicopathological correlations in corticobasal degeneration. Ann Neurol (2011) 1.86
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain (2010) 1.86
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.84
Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging (2005) 1.83
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain (2008) 1.82
Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol (2007) 1.81
Prion clearance in bigenic mice. J Gen Virol (2005) 1.79
Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord (2007) 1.78
Childhood obesity and asthma control in the GALA II and SAGE II studies. Am J Respir Crit Care Med (2013) 1.75
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain (2011) 1.73
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs (2010) 1.72
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology (2013) 1.70
Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology (2012) 1.69
Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol (2013) 1.68
Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration. Proc Natl Acad Sci U S A (2013) 1.67
Conformational transformation and selection of synthetic prion strains. J Mol Biol (2011) 1.66
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A (2002) 1.65
Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias. Neurology (2013) 1.65
Socioeconomic status and childhood asthma in urban minority youths. The GALA II and SAGE II studies. Am J Respir Crit Care Med (2013) 1.64
Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol (2004) 1.63
Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet (2011) 1.60
Measuring prions by bioluminescence imaging. Proc Natl Acad Sci U S A (2009) 1.59
Gene expression study on peripheral blood identifies progranulin mutations. Ann Neurol (2008) 1.59
Rapidly progressive dementia. Neurol Clin (2007) 1.58